Evaluation of retinoblastoma protein expression in endometrial hyperplasia.
نویسندگان
چکیده
UNLABELLED In our study we investigated immunohistochemical expression of retinoblastoma protein (pRb) in physiological endometrium (n = 15), hyperplastic endometrium (n = 61) and post-hormone replacement therapy (HRT) endometrium (n = 24). METHODS We performed an immunohistochemical analysis of pRb expression in 100 specimens of human endometrium. RESULTS The average pRb immunoexpression index score in glandular endometrial cells and stromal endometrial cells were 57,699 and 21,191 respectively. The less intense pRb immunostaining for the glandular cells was displayed in women over 49 years old. The most intense staining effect of glandular cells was observed among patients with physiological endometrium, no older than 49 years of life. There was no statistically significant correlation between the obtained pRb immunoexpression and clinical data of the examined patients. CONCLUSIONS We conclude that immunohistochemistry is not sensitive and specific enough to reveal pRb alterations resulting in endometrium pathologies. Alternatively, pathological rearrangements of endometrium may be independent from the accuracy of the pRb control over restriction point in cell-cycle pathway.
منابع مشابه
P-209: Evaluation of Common Risk Factors in Patients with Endometrial Hyperplasia
Background: One of the most common abnormality in female genital system, especially in premenopausal period, is abnormal uterine bleeding caused by endometrial hyperplasia. Prevalence of endometrial hyperplasia is 5-20% with different risk factors such as hypertension, diabetes mellitus (DM), multiparity, nuliparity, advanced age, and using estrogen consumption. This study try to determine risk...
متن کاملبررسی ایمونوهیستوشیمی بروز گیرندههای استروژن و پروژسترون در انواع هیپرپلازی و کارسینوم آندومتریویید آندومتر
Background: Endometrial carcinoma (EC) is the most common gynecologic malignancy however, mechanisms underlying its pathogenesis remain obscure. Endometrial carcinoma has been classified into two major categories: type I (related to estrogen or endometrioid adenocarcinoma) and type II (unrelated to estrogen). Estrogen is the main trigger for the abnormal proliferation in the endometrial epithel...
متن کاملبررسی بروز PTEN بهروش ایمنوهیستوشیمی در آندومتر پرولیفراتیو نرمال، هیپرپلاستیک و کارسینوم آندومتریوئید
Background: Endometrial carcinoma is the most common malignancy of the female genital tract. Different molecular alterations have been described in endometrioid endometrial carcinoma that, the most frequently altered gene is mutations of PTEN. Up to 50-83% of endometrioid carcinoma reveal altered PTEN characterized by loss of expression. In endometrial hyperplasia, which are precursors of endom...
متن کاملEvaluation of the Effect of Additive Metformin to Progesterone on Patients with Endometrial Hyperplasia
Background and Objectives: Endometrial hyperplasia (EH) is an abnormal overgrowth of endometrium that may lead to endometrial cancer, especially when accompanied by atypia. The treatment of EH is challenging, and previous studies report conflicting results. Metformin (dimethyl biguanide) is an anti-diabetic and insulin sensitizer agent, which is supposed to have antiproliferative and anticancer...
متن کاملThe expression of syndecan-1 is related to the risk of endometrial hyperplasia progressing to endometrial carcinoma.
OBJECTIVE Aberrant expression of the cell surface proteoglycan, syndecan-1, is found in many malignancies. The current study describes the immunohistochemical study of syndecan-1 expression in normal, hyperplastic, and malignant endometrial tissues for evaluation of application as a parameter of cancer progression in patients with endometrial hyperplasia. METHODS Immunohistochemical staining ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Polish journal of pathology : official journal of the Polish Society of Pathologists
دوره 58 3 شماره
صفحات -
تاریخ انتشار 2007